Moderna Inc (MRNA) Q4 2024 Earnings Call Highlights: Navigating Challenges and Strategic Shifts [Yahoo! Finance]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Yahoo! Finance
5 min read In This Article MRNA Total Revenue (2024): $3.2 billion, a 53% decline from 2023. Net Loss (2024): $3.6 billion compared to $4.7 billion in 2023. Net Product Sales (Q4 2024): $0.9 billion, with $0.2 billion in the US and $0.7 billion internationally. Net Product Sales (Full Year 2024): $3.1 billion, with $1.7 billion in the US and $1.4 billion internationally. Cash and Investments (Year-End 2024): $9.5 billion. Cost of Sales (Q4 2024): $739 million, including $238 million noncash charge for contract termination. R&D Expenses (Q4 2024): $1.1 billion, a 20% year-over-year decline. SG&A Expenses (Q4 2024): $351 million, down 25% year-over-year. Loss Per Share (Q4 2024): $2.91 compared to earnings per share of $0.55 in Q4 2023. Operating Exp
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Moderna, Inc. (NASDAQ: MRNA) is now covered by analysts at Citigroup Inc.. They set a "neutral" rating and a $40.00 price target on the stock.MarketBeat
- Here's Why Moderna Stock Soared 16% on Wednesday [Yahoo! Finance]Yahoo! Finance
- https://seekingalpha.com/article/4765429-moderna-insider-buy-signal [Seeking Alpha]Seeking Alpha
- Why Moderna, Inc. (MRNA) Went Up on Wednesday [Yahoo! Finance]Yahoo! Finance
- Why Moderna (MRNA) Stock Is Rallying Today [Yahoo! Finance]Yahoo! Finance
MRNA
Earnings
- 2/14/25 - Miss
MRNA
Sec Filings
- 3/11/25 - Form DEFA14A
- 3/11/25 - Form DEF
- 3/11/25 - Form ARS
- MRNA's page on the SEC website